Observational Medical Outcomes Partnership

Similar documents
OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP

Approach to the Patient with Liver Disease

Primary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants

Monitoring Hepatitis C

A Guide for Patients Living with a Biliary Metal Stent

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Hepatitis Panel/Acute Hepatitis Panel

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Jaundice , The Patient Education Institute, Inc. syf80102 Last reviewed: 05/05/2017 1

Tata Memorial Centre s opinion is summarized as follows: 1. Given the type 1 stricture (as mentioned in the structured summary), assessment

Hepatitis Panel/Acute Hepatitis Panel

LIVER SPECIALTY CONFERENCE USCAP Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA

Patterns of abnormal LFTs and their differential diagnosis

Postoperative jaundice

Routine Clinic Lab Studies

The authors have declared no conflicts of interest.

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014

Index. Note: Page numbers of article titles are in boldface type.

An oncology reviewer s perspective on hepatotoxicity

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Patterns of abnormal LFTs and their differential diagnosis

Figure 2: Post-cholecystectomy biliary-like pain

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Hepatitis C Virus (HCV)

Overview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

EVALUATION OF ABNORMAL LIVER TESTS

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Pathophysiology I Liver and Biliary Disease

Resident, PGY1 David Geffen School of Medicine at UCLA. Los Angeles Society of Pathology Resident and Fellow Symposium 2013

CASE 01 LA Path Slide Seminar 13 March, 08. Deepti Dhall, MD Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center

Chapter 45 3/2/2017. Care of the Patient with a Gallbladder, Liver, Biliary Tract, or Exocrine Pancreatic Disorder

Chronic Hepatitis C. Risk Factors

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Endoscopic Retrograde Pancreatography and Laparoscopic Cholecystectomy. TEAM 1 Janix M. De Guzman, MD Presentor

Disorders of the Liver, Gallbladder and Pancreas

Index. Note: Page numbers of article titles are in boldface type.

Supplementary Table 1 ICD -8 and ICD- 9 codes for liver disease and the three definitions of liver cirrhosis (LC)

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

Liver Disease in Cystic Fibrosis

Update in abdominal Surgery in cirrhotic patients

Adverse Drug Event (ADE) Anti-Coagulant Usage - OPTION #2 Measure Definition Sheet

Lipids Testing

CLINICOPATHOLOGICAL CORRELATION OF LIVER BIOPSY- STUDY OF 50 CASES

ACG Clinical Guideline: Primary Sclerosing Cholangitis

Validation of Clinical Outcomes in Electronic Data Sources

Abdominal Pain and Abnormal Liver Tests After Orthotopic Liver Transplantation

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Drug-induced liver injury

Tratamiento endoscópico de la CEP. En quien como y cuando?

Karen A. Hicks, M.D. Medical Officer Division of Cardiovascular and Renal Products Center for Drug Evaluation and Research, FDA

Pediatric PSC A children s tale

British Liver Transplant Group Pathology meeting September Leeds cases

Management of Acute HCV Infection

AMR in Liver Transplantation: Incidence

OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP


Liver Disease. By: Michael Martins

Cholangiocarcinoma (Bile Duct Cancer)

Patologia sistematica V Gastroenterologia Prof. Stefano Fiorucci Autoimmune liver diseases

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006

Extrahepatic Biliary Obstruction. Ductal Diseases: Stones Tumors. Acute Injury: Viral Hepatitis Toxin (APAP/Etoh) Reye s Shock.

CrackCast Episode 28 Jaundice

OP-10: ABDOMEN CT USE OF CONTRAST MATERIAL

Biliary tree dilation - and now what?

Management of Gallbladder Disease

Case Scenario 1. Discharge Summary

Gastrointestinal System: Accessory Organ Disorders

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

Research Article Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver Function Tests

Hépatopathies auto-immunes

The campaign on laboratory: focus on Gallstone Disease and ERCP

Chronic Hepatic Disease

Tapazole Methimazole Tablets, USP DESCRIPTION

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Yes, the proposed stopping rules are too conservative. John R. Senior, M.D. 25 March 2010 Rethink Stopping Rules 1

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane.

Pediatric Primary Sclerosing Cholangitis and Potential Therapies

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

What Are Gallstones? GALLSTONES. Gallstones are pieces of hard, solid matter that form over time in. the gallbladder of some people.

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

Imaging Guided Biopsy. Edited & Presented by ; Hussien A.B ALI DINAR. Msc Lecturer,Reporting Sonographer

Subject ID: I N D # # U A * Consent Date: Day Month Year

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

Interpreting Your Tests

During the course of the 12 month fellowship, candidates will attend at least one international liver meeting (generally AASLD).

Interpreting Liver Function Tests

Applied Health Economics and Health Policy

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS

Comparative Study of the Serum Bilirubin and Various Other Liver Related Enzymes in Different Types of Jaundice

Jaundice Chris Wells Regional CMT teaching 6 th June 2017

Barnes, Maisha. Habib, Adil. Kedia, Prashant

A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK

Transcription:

Implications of Health Outcomes of Interest Definitions: Acute Liver Injury Case Study Judy Racoosin, Patrick Ryan on behalf of OMOP Research Team Observational Medical Outcomes Partnership Established to inform the appropriate use of observational healthcare databases for active surveillance by: Conducting methodological research to empirically evaluate the performance of alternative methods on their ability to identify true drug safety issues Developing tools and capabilities for transforming, characterizing, and analyzing disparate data sources Establishing a shared resource so that the broader research community can collaboratively advance the science 2

OMOP research experiment workflow OMOP Methods Library Method 1 Method 2 Method 3 Method 4 Common Data Model feasibility testing Health Outcomes of Interest Angioedema Aplastic Anemia Acute Liver Injury Bleeding GI Ulcer Hospitalization Hip Fracture Hospitalization Myocardial Infarction Mortality after MI Renal Failure Drugs ACE Inhibitors Amphotericin B Antibiotics Antiepileptics Benzodiazepines Beta blockers Bisphosphonates Tricyclic antidepressants Typical antipsychotics Warfarin Non specified conditions All outcomes in condition terminology Labeled events as reference Warning Precautions Adverse Reactions Postmarketing Experience 3 Setting Use of observational data for active drug safety surveillance requires using algorithms based on diagnosis codes and other clinical information to identify cases of given health outcomes of interest (HOIs) OMOP contractors performed systematic reviews of the literature for a range of HOIs to determine what algorithms had been previously studied and shown to have good positive predictive value (PPV) for detecting cases The systematic review for the HOI acute liver injury (ALI) did not identify any algorithms that had good PPV Based on the codes that were used in the ALI validation studies, OMOP investigators fashioned a series of HOI definitions Diagnosis codes were grouped into broad and narrow categories Requirement for relevant procedures and labs was added to some of the definitions to investigate the potential for improved capability for identifying cases 4

Acute liver injury (ALI) definitions ALI 1: Occurrence of at least one broad diagnosis code ALI 2: Occurrence of at least one narrow diagnosis code ALI 3: Occurrence of at least one narrow diagnosis code AND (diagnostic procedure <=30d before OR treatment procedure >=60d after) ALI 4: Occurrence of at least one narrow diagnosis code AND (diagnostic procedure <=30d before OR treatment procedure >=60d after) AND laboratory results indicative of Hy s law: ALT >= 3xULN AND AST >= 3xULN AND Bilirubin >= 2xULN within 7 days ALI 5: Laboratory results indicative of Hy s law: ALT >= 3xULN AND AST >= 3xULN AND Bilirubin >= 2xULN within 7 days ALI 6: Laboratory results strongly indicative of Hy s law: ALT >= 10xULN AND AST >= 10xULN AND Bilirubin >= 2xULN within 7 days 5 Impact of alternative HOI definitions HOI definition 6

ALI cohort totals Acute Liver Injury Prevalence Database 7 How can OMOP s data characterization tools refine use of HOI algorithms in active surveillance? Improve accuracy of HOI case identification Improve the likelihood that an identified HOI case is drug related 8

Natural History Analysis (NATHAN) OSCAR provides a systematic approach for summarizing all data within the OMOP common data model Natural History Analysis (NATHAN) is an extension of OSCAR, where data characteristics can be produced for a particular subpopulation of interest Exposed population (e.g. patients taking antibiotics) Cases (e.g. patients with acute liver injury) Exposed cases (e.g. patients taking antibiotics who develop acute liver injury) Additional NATHAN summary statistics provide temporal assessment, relative to index date Ex. conditions 30d prior to drug start Ex. drug exposure any time prior to incident condition Use NATHAN to refine HOI algorithms in active surveillance Evaluate alternative cohort definitions (HOIs) Comparisons between data sources http://omop.fnih.org/nathan 9 Page 9 Factors to consider when identifying acute liver injury cases Demographic assessment Case distribution by gender Case distribution by age 10

NATHAN ALI cohort: gender Gender 11 NATHAN ALI cohort: year of birth distribution Year of 12

Factors to consider when identifying acute liver injury cases Evidence of hepatocellular injury: Symptoms and Signs Nausea/Vomiting Abdominal pain/ Right Upper Quadrant Pain Jaundice Laboratory tests Elevated ALT/Bilirubin Elevated prothrombin time (PT) or INR Procedures Liver biopsy Liver transplant following the index diagnosis 13 Symptoms and signs recorded as diagnosis codes Conditions 14

Laboratory tests/ Diagnostic procedure Test or Procedure Name 15 Treatment procedures after index diagnosis 16

Factors to consider when identifying acute liver injury cases: pertinent negatives Evidence of an obstructive cause Diagnoses Pancreatic cancer Common bile duct stone Laboratory tests Elevated alkaline phosphatase Procedures ERCP (Endoscopic retrograde cholangiopancreatography) Common bile duct stenting 17 Pertinent negatives: diagnoses 18

Factors to consider when identifying druginduced liver injury cases Rule out alternative cause of acute liver injury Exposures Other hepatotoxic drugs Diagnoses Viral hepatitis Autoimmune hepatitis Alcoholic hepatitis Hepatic cirrhosis Procedures Liver transplant before the index diagnosis Laboratory tests Viral serologies Autoantibodies Treatments Antiviral drugs for HBV Antiviral drugs for HCV 19 Alternative causes of acute liver injury: diagnoses Conditions 20

Alternative causes of acute liver injury: treatments for viral hepatitis Drugs 21 Implications for future development of HOI definitions There will be HOIs which have not been well validated in the literature or have algorithms identified with good PPV Use of a tool like NATHAN can help to refine a potential HOI definition by identifying diagnosis codes, procedure codes, and lab abnormalities that occur commonly in the population of interest and explore potential exclusion criteria Refinement of an HOI definition may be tested by using NATHAN to develop potential variations of an HOI algorithm and then validating the various algorithms in a database that can access source records 22

OMOP Contact information Thomas Scarnecchia Executive Director scarnecchia@omop.org Emily Welebob Senior Program Manager, Research welebob@omop.org OMOP website: http://omop.fnih.org 23 Backup 24

Broad and narrow diagnosis code based definitions for acute liver injury Definition 1 Broad: 277.4 Disorders of bilirubin excretion 570* Acute and subacute necrosis of the liver 572.2 Hepatic coma (hepatorenal syndrome) 572.4* Hepatorenal syndrome 573* Other disorders of the liver, including chemical or drug induced 576.8 Other specified disorders of biliary tract 782.4 Jaundice, unspecified, not of newborn 789.1* Hepatomegaly 790.4* Nonspecific elevation of transaminase or lactic dehydrogenase levels 794.8* Abnormal liver function test results Definition 2 Narrow: 570* Acute and subacute necrosis of the liver 572.2 Hepatic coma (hepatorenal syndrome) 572.4* Hepatorenal syndrome 573* Other disorders of the liver, including chemical or drug induced 25 Codes included as acute liver injury procedures Diagnostic procedures Code Vocabulary Description 47000 CPT Biopsy of liver, needle; percutaneous 47001 CPT Biopsy of liver, needle; when done for indicated purpose at time of other major procedure (List separately in addition to code for primary procedure) 47100 CPT Biopsy of liver, wedge 78205 CPT Liver imaging (SPECT); 78206 CPT Liver imaging (SPECT); with vascular flow 50.11 ICD9 Procedure Closed (percutaneous) [needle] biopsy of liver 50.14 ICD9 Procedure Laparoscopic liver biopsy 50.12 ICD9 Procedure Open biopsy of liver 50.91 ICD9 Procedure Percutaneous aspiration of liver 50.13 ICD9 Procedure Transjugular liver biopsy Therapeutic procedures Plus 34 LOINC codes for Liver CT, MR, SPECT, and US Code Vocabulary Description 47136 CPT Liver allotransplantation; heterotopic, partial or whole, from cadaver or living donor, any age 47135 CPT Liver allotransplantation; orthotopic, partial or whole, from cadaver or living donor, any age 50.51 ICD9 Procedure Auxiliary liver transplant 50.5 ICD9 Procedure Liver transplant 50.59 ICD9 Procedure Other transplant of liver 39694-5 LOINC Liver Transplant RI W RNC IV 39454-4 LOINC Liver Transplant US 38765-4 LOINC Liver Transplant US Bx guid 30706-6 LOINC Liver US in Surg http://omop.fnih.org/acuteliverinjury 26